Mouse models for studies of cardiovascular complications of type 1 diabetes (Q36766171)

16 August 2017

Mouse models for studies of cardiovascular complications of type 1 diabetes (English)

1 reference

16 August 2017

0 references

2

Karin E Bornfeldt

1 reference

16 August 2017

Xia Shen

1

1 reference

PubMed ID

17376839

16 August 2017

language of work or name

English

0 references

publication date

21 March 2007

1 reference

Annals of the New York Academy of Sciences

16 August 2017

1 reference

16 August 2017

1103

1 reference

16 August 2017

202-217

1 reference

Diabetes as an atherogenic factor.

16 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Diabetes and hypertension: pathogenesis, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Carotid artery intima-media thickness in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Diabetic cardiomyopathy: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Diabetic vascular disease: an experimental objective

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Diabetes-induced accelerated atherosclerosis in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Rupture of the atherosclerotic plaque: does a good animal model exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Genetic background determines response to hemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Tissue-specific hemostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

21 January 2018

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Calmodulin-induced early-onset diabetes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Overexpression of metallothionein reduces diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

Lipid overload and overflow: metabolic trauma and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1394.004

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1394.004

1 reference

release_utduinfmnvbcnceiqe4mk3ofmi

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/utduinfmnvbcnceiqe4mk3ofmi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17376839

1 reference

PubMed ID

17376839